Dechert Advises CTRS in OBO Transaction
December 11, 2020
Dechert advised the shareholders of CTRS, a French pharmaceutical company which specializes in rare diseases, in connection with its OBO transaction in which Mérieux Equity Partners, a global investment platform specialized in the healthcare sector, has acquired a stake in the group.
This new financial partnership will enable CTRS to strengthen its leading position in the field of rare diseases.
Dechert’s multi-disciplinary team was led by Alain Decombe, Sabina Comis and Xavier Leroux, and advised CTRS on the following aspects:
- Corporate/M&A: Alain Decombe, partner and Xavier Leroux, senior associate, assisted by Benhouda Derradji and Charlotte Torck, associates
- Tax structuring aspects: Sabina Comis, partner, assisted by Etienne Bimbeau, associate
- Financing: Guénaëlle Taroni and Marianne Sajus, associates
- Regulatory: Sophie Pelé, national partner
About Dechert
Dechert is a leading global law firm with 26 offices around the world. We advise on matters and transactions of the greatest complexity, bringing energy, creativity and efficient management of legal issues to deliver commercial and practical advice for clients.
Related Professionals
